Atlas Trials

Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)

Clinical trial NCT04490031 · RECRUITING

Trial details

NCT number
NCT04490031
Sponsor
Universiti Kebangsaan Malaysia Medical Centre
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Ketamine Adverse Reaction
Start date
2020-03-01
Primary completion
2020-12-31
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.